New Delhi [India], Mar. 3 (ANI): The Delhi High Court on Friday gave a green signal to pharmaceutical companies Biocon and Mylan to manufacture and sell biosimilar drug Trastuzumab for early breast and metastatic gastric cancer.
New Delhi, July 28 (ANI- Business Wire India): Biocon branded formulations business announced the launch of a new patient support program 'Ek Prayaas' through a nationwide awareness drive for Hepatitis C on the occasion of 'World Hepatitis Day' on July 28th.
New Delhi, July 17 (ANI): Biocon on Saturday announced that its partner Fujifilm Pharma Co would launch bio-similar product Insulin Glargine in Japan after receiving approval from the Japanese health authority earlier this year.